Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy have?
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy has 460 citations in the OpenAlex counts ScholarIQ stores.
When was Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy published?
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy has 2003 year in the ScholarIQ index.
What is the open-access status of Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy?
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy has bronze oa status in the ScholarIQ index.
What is the DOI of Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy?
The DOI for Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy is on the source record.
What is the PMID of Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy?
The PMID for Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy is on the source record.
What is the OpenAlex record for Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy?
The OpenAlex for Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy is on the source record.